Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples